Physician

Luke M Williams, MD

According to 2025 Medicare claims, Luke Williams, MD (NPI: 1659347854) practices pulmonary disease in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is IMPERIAL HEALTH, LLP (NPI: 1053352401; TIN: 721005645) and primary practice location at 70601-5724. Williams is affiliated with the Aledade 35 Lagniappe MSSP Enhanced (ACO ID: A3899), participating under the MSSP model.

Williams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 924 traditional Medicare patients, billed 6,821 HCPCS/CPT codes, and received $309,302 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,383 prescription claims across 372 beneficiaries totaling $1,388,287 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,465 claims. Open Payments data shows 131 records totaling $2,579. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $420,555 to $1,388,287. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,087	5,684	$361,423
2016	1,055	5,525	$339,079
2017	960	5,004	$304,687
2018	983	4,813	$322,558
2019	999	4,908	$346,878
2020	778	3,961	$281,799
2021	581	3,403	$192,803
2022	563	4,082	$206,011
2023	897	5,092	$288,028
2024	924	6,821	$309,302

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	348	2,552	$420,555
2016	383	2,263	$632,162
2017	339	1,828	$567,214
2018	302	1,799	$541,117
2019	322	1,740	$815,442
2020	261	1,485	$1,029,030
2021	246	1,361	$1,093,007
2022	270	1,536	$778,095
2023	312	1,843	$1,054,971
2024	372	2,383	$1,388,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	423	2,359	$273,860
2016	400	2,079	$280,360
2017	265	1,653	$263,043
2018	257	1,324	$204,768
2019	253	1,694	$313,363
2020	255	1,678	$361,973
2021	180	1,254	$267,323
2022	156	1,174	$281,546
2023	186	1,253	$286,230
2024	235	1,465	$338,307

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	455	689	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	382	471	$60
94729	Test to examine how well the lungs exchange gases	267	313	$38
71046	X-ray of chest, 2 views	518	636	$21
94010	Test to measure expiratory airflow and volume	634	1,010	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	416	19,228	$398,565
Ofev	Nintedanib Esylate	27	810	$371,356
Dupixent Pen	Dupilumab	45	1,484	$215,077
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	93	3,784	$78,834
Breo Ellipta	Fluticasone/Vilanterol	83	3,630	$46,191

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	16	143	$127,318
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	19	116	$88,459
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$29,564
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	13	$22,332
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	28	202	$17,164

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$2,579	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Luke M. Williams, MD?

Tedicare shows public-source Medicare data for Luke M. Williams, MD (NPI 1659347854), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luke M. Williams, MD have ACO affiliation data?

Luke M. Williams, MD is shown with ACO affiliation data for Aledade 35 Lagniappe MSSP Enhanced (MSSP, ACO ID A3899).

What billing organization is linked to Luke M. Williams, MD?

Luke M. Williams, MD is linked to IMPERIAL HEALTH, LLP (billing NPI 1053352401) in the available physician profile data.

Does Luke M. Williams, MD have Open Payments data?

Luke M. Williams, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.